What is Fios Genomics?
Fios Genomics provides advanced bioinformatics data analysis services, catering to pharmaceutical companies, contract research organizations (CROs), and academic institutions. Their comprehensive suite of analyses, including gene expression, single-cell analysis, and proteomics, is designed to accelerate drug discovery and development pipelines. By converting complex biological data into clear, actionable intelligence, Fios Genomics empowers clients to achieve research breakthroughs and validate critical findings. The company is also recognized for its commitment to sustainability as an SME Climate Hub participant.
How much funding has Fios Genomics raised?
Fios Genomics has raised a total of $2.8M across 4 funding rounds:
Private Equity
$817K
Series B
$710K
Other Financing Round
$795K
Series C
$509K
Private Equity (2011): $817K with participation from Scottish Enterprise and Archangel Informal Investment
Series B (2011): $710K led by Archangels and TRICAPITAL
Other Financing Round (2013): $795K supported by Archangel and Tweed Renaissance Investors Capital
Series C (2014): $509K featuring Tweed Renaissance Investors Capital
Key Investors in Fios Genomics
Scottish Enterprise
Scottish Enterprise is a national economic development agency of the Scottish Government, focused on driving economic growth and innovation within Scotland.
Archangel Informal Investment
Archangel Informal Investment is an angel investment group that backs early-stage companies, likely focusing on innovative ventures with high growth potential.
Tweed Renaissance Investors Capital
Tweed Renaissance Investors Capital (TRI Cap) is a business angel syndicate that invests in growth-oriented businesses, particularly within the Scottish Borders and surrounding regions.
What's next for Fios Genomics?
With a significant enterprise-level funding context, Fios Genomics is poised for accelerated expansion and innovation. The recent capital infusion is expected to bolster its service offerings, enhance its analytical platforms, and potentially expand its market reach within the pharmaceutical and biotechnology industries. This strategic backing will likely enable Fios Genomics to deepen its impact on drug discovery and development, solidifying its position as a key player in the bioinformatics data analysis landscape. The company's focus on transforming raw biological data into actionable insights positions it for continued success in a data-intensive scientific environment.
See full Fios Genomics company page
